Bivalirudin versus Heparin Monotherapy in Myocardial InfarctionDavid Erlinge, Stefan James, Anders Lundin et al.|New England Journal of Medicine|2017Cited by 298
Prasugrel 5 mg in the Very Elderly Attenuates Platelet Inhibition But Maintains Noninferiority to Prasugrel 10 mg in Nonelderly PatientsDavid Erlinge, Dominick J. Angiolillo, Paul A. Gurbel et al.|Journal of the American College of Cardiology|2013Cited by 94
Reduction in Platelet Reactivity With Prasugrel 5 mg in Low-Body-Weight Patients Is Noninferior to Prasugrel 10 mg in Higher-Body-Weight PatientsDavid Erlinge, Kenneth J. Winters, Jurriën M. ten Berg et al.|Journal of the American College of Cardiology|2012Cited by 83
Combined Treatment With Exercise Training and Acarbose Improves Metabolic Control and Cardiovascular Risk Factor Profile in Subjects With Mild Type 2 DiabetesHenrik Wagner, Peter Båvenholm, Marie Degerblad et al.|Diabetes Care|2006Cited by 57
Higher body weight patients on clopidogrel maintenance therapy have lower active metabolite concentrations, lower levels of platelet inhibition, and higher rates of poor responders than low body weight patientsHenrik Wagner, David Erlinge, Dominick J. Angiolillo et al.|Journal of Thrombosis and Thrombolysis|2013Cited by 30